This inventor holds 34 USPTO granted patents and 10 published patent applications and 9 EPO patents, primarily in Synthetic Antibody Libraries. Top assignees: Glycofi, Incorporated, Metabolix, Inc., Adimab, LLC. Active years: 2001-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, MA (US) (2001 - 2003)
- Hanover, NH (US) (2001 - 2019)
- Lebanon, NH (US) (2021)
Company Filing History:




Years Active: 2001-2026
Areas of Expertise:
Title: The Innovative Journey of Tillman U Gerngross
Introduction:
Tillman U Gerngross, a distinguished inventor hailing from Hanover, NH (US), is renowned for his groundbreaking contributions to the field of biotechnology and beyond. His relentless pursuit of innovation has led to numerous patents and transformative discoveries.
Latest Patents:
Tillman U Gerngross holds a series of recent patents in the realm of biopharmaceuticals, including novel methods for protein engineering and drug development. These patents showcase his ongoing commitment to pushing the boundaries of scientific advancement.
Career Highlights:
With a stellar academic background and extensive industry experience, Tillman U Gerngross has established himself as a trailblazer in the world of biotechnology. His work spans across various prestigious institutions and companies, where he has spearheaded cutting-edge research projects.
Collaborations:
Throughout his illustrious career, Tillman U Gerngross has collaborated with leading experts in the field, fostering a culture of innovation and knowledge exchange. His partnerships have resulted in groundbreaking inventions and have paved the way for future advancements in biotechnology.
Conclusion:
In conclusion, Tillman U Gerngross stands as a visionary inventor whose passion for innovation has reshaped the landscape of biotechnology. His remarkable journey continues to inspire aspiring inventors and researchers worldwide, leaving an indelible mark on the realm of scientific discovery.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
